3
Participants
Start Date
December 17, 2020
Primary Completion Date
January 22, 2022
Study Completion Date
January 22, 2022
Blinatumomab
15 mcg/m2/day for 28 days
St. Anna Kinderspital, Vienna
University Hospital Gasthuisberg (UZ Leuven), Leuven
Motol University Hospital Prague, Prague
Rigshospitalet Copenhagen, Copenhagen
Hôpital Robert Debré, Paris, Paris
Ospedale S. Gerardo Monza, Monza
IRCCS Ospedale Pediatrico Bambino Gesù Roma, Roma
Oslo University Hospital, Oslo
Nicolaus Copernicus University Collegium Medicum, Bydgoszcz
Lublin, Medical Academy, Lublin
University of Medical Sciences Poznan, Poznan
Klinika Transplantacji Szpiku, Wroclaw
University Children's Hospital, Bratislava
Hospital Universitario Vall d'Hebron, Barcelona
Collaborators (1)
Amgen
INDUSTRY
Prof. Christina Peters
OTHER